Meerkat, the live broadcasting app, has raised $12 million in Series B funding led by Greylock’s Josh Elman, TechCrunch reports. The deal reportedly values Meerkat at $52 million and other unknown angels are said to be involved. Twitter recently purchased a Meerkat competitor, Periscope, and shut down part of Meerkat’s access to Twitter. The app allows one person to broadcast to many.
Corsa Technology, a software defined networking (SDN) company, has closed a $16.5 million Series B round of financing, led by Roadmap Capital with participation from previous investors including Celtic House Venture Partners and BDC Capital. “Corsa has effectively redefined the nature of networking by providing the ability to efficiently scale to meet the needs of a new generation of applications,” said Tomas Valis, Partner at Celtic House. “Having backed the Corsa team from day one, we are very pleased with their progress in bringing to market, in record time, an entirely new class of product designed specifically for SDN. With this latest round of funding in place, Corsa is well-positioned to deliver on the market demand for secure and scalable cloud-based networks.”
Index Ventures has led a funding round into Property Partner, a crowdfunding platform for residential property, worth $7.8 million. The company was established in January and its early backers include Jon Moulton of Better Capital, Seedcamp and Ed Wray, the co-founder of Betfair.
OrthoSensor, which develops sensor-assisted surgery technology, has raised $19 million in a private placement of Series C preferred stock. The Tullis Growth Fund and Bridger Healthcare participated in the funding. “Our proprietary technologies are providing orthopaedic surgeons with valuable new tools to enhance clinical outcomes and deliver greater patient satisfaction following total knee arthroplasty procedures,” said Ivan Delevic, President and Chief Executive Officer of OrthoSensor. “We have an exciting path forward and believe that the support of high-profile investors such as Bridger Healthcare and The Tullis Growth Fund illustrates broad potential impact of our technology in the future of orthopaedics.”